Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Synvista Therapeutics Inc. (SYNI) had Return on Tangible Equity of -62.73% for the most recently reported fiscal quarter, ending 2008-09-30.
| Income Statement Financials | |
$0.00M |
|
$-2.87M |
|
-- |
|
$0.00M |
|
$2.92M |
|
$-2.92M |
|
$0.05M |
|
$-2.87M |
|
$-2.87M |
|
$-2.87M |
|
$-2.87M |
|
$-2.87M |
|
$-2.87M |
|
$-2.92M |
|
$-2.92M |
|
2.59M |
|
2.59M |
|
$-1.96 |
|
$-1.96 |
|
| Balance Sheet Financials | |
$8.39M |
|
-- |
|
$0.32M |
|
$8.74M |
|
$4.16M |
|
-- |
|
-- |
|
$4.16M |
|
$4.48M |
|
$4.58M |
|
$4.57M |
|
-- |
|
| Cash Flow Statement Financials | |
$-7.67M |
|
$-0.01M |
|
$0.00M |
|
$15.64M |
|
$7.95M |
|
$-7.68M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.02 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-7.68M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-64.13% |
|
|
Return on Tangible Equity |
-62.73% |
-32.87% |
|
-62.87% |
|
-- |
|
$-2.97 |
|
$-2.97 |
|